Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
02/09/2023 | Lexaria Bioscience Corp. | LEXX | Purchase | Common Shares | 1.5k | $2.84 | $4.3k | | 02/09/2023 |
10/12/2022 | Lexaria Bioscience Corp. | LEXX | Grant | Stock Options | 1.6k | $1.96 | $3.1k | | 10/12/2022 |
09/02/2022 | Lexaria Bioscience Corp. | LEXX | Grant | Stock Options | 3.4k | $3.04 | $10.3k | | 09/02/2022 |
03/19/2020 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 100k | $0.26 | $26k | | 03/19/2020 |
09/26/2019 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 75k | $0.67 | $50.2k | | 09/26/2019 |
05/21/2019 | Eledon Pharmaceuticals, Inc. | NVUS | Sale | Common Stock | 1.9k | $1.91 | $3.7k | | 05/20/2019 |
05/20/2019 | Eledon Pharmaceuticals, Inc. | NVUS | Sale | Common Stock | 7.6k | $1.96 | $15k | | 05/20/2019 |
03/14/2019 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 50k | $3.72 | $186k | | 03/14/2019 |
03/14/2019 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Common Stock | 20k | $0.00 | $0 | | 03/14/2019 |
09/12/2018 | Eledon Pharmaceuticals, Inc. | NVUS | Purchase | Common Stock | 16.6k | $5.02 | $83.5k | | 09/11/2018 |
09/11/2018 | Eledon Pharmaceuticals, Inc. | NVUS | Purchase | Common Stock | 17k | $4.56 | $77.7k | | 09/11/2018 |
09/05/2018 | Eledon Pharmaceuticals, Inc. | NVUS | Purchase | Common Stock | 805 | $3.97 | $3.2k | By Spouse's IRA | 09/05/2018 |
03/13/2018 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 24k | $4.83 | $115.9k | | 03/13/2018 |
03/13/2018 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Common Stock | 20k | $0.00 | $0 | | 03/13/2018 |
11/06/2017 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 50k | $4.21 | $210.5k | | 11/06/2017 |
05/24/2017 | Eledon Pharmaceuticals, Inc. | NVUS | Grant | Stock Option (Right to Buy) | 52.5k | $5.50 | $288.8k | | 05/24/2017 |